|
1990: Creation
At the end of 1990, the Picardie Regional Council and
the Somme General Council launched the idea of a serobank
in Picardie.
1991: The Biobanque de Picardie takes shape
The Somme General Council and the Picardie Regional
Council invest in the project, providing grants for the
construction, functioning and equipment of the Biobanque.
1992: First steps
Laboratories throughout the Picardie region are
informed of the Biobanque de Picardie's creation.
The first straw is stored
Application is broadened to other types of biological
material (DNA, RNA etc.), giving rise to the concept of a
"Biobanque", a bank of biological material.
1993: Development
The European Chlamydia Network chooses the Biobanque de
Picardie as its head office for Chlamydia serum samples (a
decision made during the meeting in Southampton on
February 26th and 27th, 1993).
1994: Know-how favours collaborations
Straws first sent to other European countries
Study of the relationship between clinical symptoms and
serological results in Chlamydia pneumoniae
infections (in collaboration with the Amiens Prevention
and Health Examination Centre).
Collaboration with a diagnostics company, leading to a
contract for improving a diagnostic kit in June 1995.
1995: Numerous studies...
A study on papillomaviruses is launched
(in collaboration with the Amiens Centre of Obstetrics and
Gynaecology and the Reims Regional Hospital).
Multicentre study in Picardie on pneumopathies
Creation of an anti-phospholipid syndrome and antibody
network (in collaboration with the Compiègne Hospital and
the Technology University of Compiègne)
Collaboration with the Rheumatology Department
as part of the regional, multicenter, INSERM U21 protocol
on vitamin D.
1996:
Comparison of different molecular biology and
immunofluorescence techniques for the detection of Chlamydia
trachomatis in urine and genital samples.
1997:
Study of cardiovascular risk factors in children (in
collaboration with the Picardie Regional Health
Observatory).
1998:
Collaborative study of the prevalence of Chlamydia
pneumoniae and Mycoplasma pneumoniae in asthmatic adults.
Development of a protocol for the diagnosis of
haemochromatosis in a healthy population.
|